FMC Corp vs Thomson Reuters Corp — how do they compare? FMC Corp trades at $11.42 (market cap $1.36B), while Thomson Reuters Corp trades at $99.88 (market cap $41.16B). The key difference: Thomson Reuters Corp is far larger — about 30.3× FMC Corp's market cap, and FMC Corp pays the higher dividend (2.95%). Which is the better fit depends on your goals.
| FMC | TRI | |
|---|---|---|
Market Cap | $1.36B | $41.16B |
Sector | Basic Materials | Industrials |
52-Week High | $43.90 | $211.14 |
52-Week Low | $10.72 | $76.55 |
Enterprise Value | $5.50B | $43.12B |
Dividend Yield | 2.95% | 2.74% |
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.
The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.
Thomson Reuters (TRI) trades at $100.30, up 9.33% in the past 24 hours, reflecting strong momentum. The stock shows a bullish technical signal with moving averages and ADX supporting upward trends, though RSI indicates potential overbought conditions. Fundamentally, the company maintains robust profitability with a 19.93% net income margin and has beaten earnings estimates in two of the last three quarters. Recent developments include a joint venture with KKR for its global print business and continued AI integration, signaling strategic growth initiatives.
The outlook for TRI is positive, driven by analyst consensus favoring a Buy rating with a $129.96 price target, implying significant upside. Key opportunities lie in AI adoption and partnership expansions, but risks include execution challenges in technology transitions and potential revenue volatility. Investors should weigh strong fundamentals against near-term overbought technicals and competitive pressures in the information services sector.
Trailing returns across standard periods
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →Thomson Reuters is the result of the $17.6 billion megamerger of Canada's Thomson and the United Kingdom's Reuters Group in 2008 and the 2018 carve-out of its finance and risk business, Refinitiv, in which it holds a 45% stake. In 2019, the company agreed to exchange its 45% stake in Refinitiv for a 15% stake in LSE, which closed in early 2021. Since the divestiture, the company is more concentrated on selling its flagship legal data and software, Westlaw, and its tax accounting software, Onesource. Reuters sees roughly 80% of revenue and 70% of expenses attributed to the United States, while the remainder (largely through the global print and Reuters News segments) is distributed across Latin America, Europe, the Middle East, Africa, and Asia-Pacific.
Read more on TRI →